


Imagin Medical
Biotechnology Research • Auburndale, Massachusetts, United States • 1-10 Employees
Company overview
| Headquarters | 275 Grove St, Suite 2-400, Auburndale, Massachusetts 02466, US |
| Phone number | +16175716006 |
| Website | |
| NAICS | 541714 |
| SIC | 384 |
| Employees | 1-10 |
| Socials |
Key Contact at Imagin Medical
Imagin Medical
Company Owner
About Imagin Medical
Through visionary innovation in endoscopic technology, Imagin Medical is working towards the prevention of bladder cancer recurrence. Imagin is a surgical imaging company focused on allowing physicians to clearly and accurately visualize cancer cells during minimally invasive procedures, resulting in more precise, effective, and efficient treatment of bladder cancer. Imagin’s i/Blue Imaging System, which combines white and blue light with fluorescent imaging agents, provides physicians a dramatically improved view of all cancerous cells when compared with conventional white light endoscopy systems. This enables improved removal of the tumor, minimizing the need for additional procedures and the risk of metastasis. Imagin Medical is a publicly traded company listed on the Canadian Securities Exchange (CSE: IME) (OTCQB: IMEXF) (Frankfurt & Stuttgart Symbol: DPD2).For more information, please visit our website at www.imaginmedical.com.
Imagin Medical revenue & valuation
| Annual revenue | $513,330 |
| Revenue per employee | $86,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues | $1,700,000 |
| Total funding | $7,300,000 |
Employees by Management Level
Total employees: 1-10
Seniority
Employees
Imagin Medical Tech Stack
Discover the technologies and tools that power Imagin Medical's digital infrastructure, from frameworks to analytics platforms.
Security
Form builders
UI frameworks
Maps
JavaScript libraries
CDN
JavaScript libraries
Miscellaneous
Programming languages
WordPress plugins
Blogs
Frequently asked questions
4.8
40,000 users



